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Abstract We report that immunohistochemical staining for
cellular retinoic acid-binding protein (CRABP) was restricted to
the cytoplasm of cortical cells in bovine adrenal. In contrast,
staining for the similar protein, cellular retinol-binding protein
(CRBP), was found throughout these cells. After transfections of
CRABP and CRBP into cultured cells, immunofluorescence
analyses again revealed cytoplasmic restriction only for CRABP,
with a pronounced punctate appearance. Use of organelle-
specific fluorochromes indicated that CRABP immunofluores-
cence overlaid exactly with the pattern of the mitochondrial-
specific fluorochrome. Confirmation of this association came
with subcellular fractionation of the adrenal cortex. CRABP, but
not CRBP, co-sedimented with the mitochondria, a novel finding
for a member of this superfamily of cellular lipid-binding
proteins. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Retinoic acid (RA) is an active hormonal form of the es-
sential micronutrient vitamin A. This hormone exerts its ef-
fects on a cell by binding to its cognate RA receptors (RARs).
The active receptor^ligand complex binds to RA response
elements and alters the transcriptional rates of speci¢c genes
[1]. Since at least one of the three known RARs is expressed in
most, if not all, mammalian cell types, mechanisms for regu-
lating access of RA to the nucleus would appear necessary.
Part of such mechanisms may involve the 15.5 kDa protein,
cellular RA binding protein (CRABP or CRABP, type 1) [2].
This protein has been shown to speci¢cally bind RA with
nanomolar a⁄nities [3,4]. There are several reports that sug-
gest CRABP may protect the cell from the genomic action of
RA by sequestering the compound and accelerating its catab-
olism [5,6]. RA bound to CRABP has been demonstrated to
be a substrate for oxidation by members of the P450 family
[7].
A potential key to attenuation of the RA signal may be
found in the speci¢c location of CRABP within the cell. Im-
munohistochemical experiments performed on tissue sections
by our laboratory has revealed that this protein is restricted to
the cytoplasmic compartment of cells, even though its size
should enable free entry into the nucleus [8]. This nuclear
restriction might create a barrier that prevents RA from
reaching the RARs in the nucleus. However, the mecha-
nism(s) by which this restriction is accomplished has not
been established. Conversely, Gustafson et al. have reported
immunohistochemical analysis of tissue sections and observed
CRABP staining restricted to the cytoplasm of some cells but
in the nucleus of others [9]. However, this report demon-
strated that, following transfection of cells with CRABP
cDNA, the expressed protein detected by immuno£uorescence
was nuclear excluded in all cells. One additional study re-
ported both nuclear exclusion or inclusion, depending on their
experimental conditions. They suggested that the apparent
nuclear exclusion observed by immunohistochemistry or im-
muno£uorescence may have resulted from antibody or ¢xa-
tion artifacts [10]. In this study, we demonstrate that CRABP
is localized to the mitochondria. This association with the
mitochondria e¡ectively restricts it to the cytosolic compart-
ment of the cell and suggests a role for mitochondria in ret-
inoid metabolism.
2. Materials and methods
2.1. Materials
The Cos-1 and NIH 3T3 cell lines were from ATCC. ST15A cells
were a gift from R. McKay. The pCMX vector was a gift from C.
Tucker [11]. Polyclonal antibodies to CRABP and cellular retinol-
binding protein (CRBP) were generated by this laboratory as previ-
ously described [12,13]. The antibody to cytochrome c was from Phar-
mingen (San Diego, CA, USA). Alexa Fluor 488 labeled goat anti-
rabbit IgG was from Molecular Probes (Eugene, OR, USA). Organ-
elle-speci¢c £uorochromes were from Molecular Probes (Eugene, OR,
USA). All oligonucleotides were synthesized by the Vanderbilt Uni-
versity Diabetes Core. Lipofectamine was from Life Technologies
(Rockville, MD, USA). The alkaline phosphatase substrate used
was from DAKO Corporation (Carpinteria, CA, USA). Aquamount
was from Harlan. All other reagents were from Sigma.
2.2. Immunohistochemistry
Staining of bovine adrenal samples was performed as previously
described [14].
2.3. DNA constructs
cDNA primers to the 5P and 3P ends of CRABP and CRBP that
would incorporate restriction sites convenient for subcloning were
used for PCR ampli¢cation. The products of these reactions were
cloned into the pCMX vector [11].
2.4. Cellular transfections
ST15A cells in DMEM/F12 plus 10% fetal bovine serum, COS-1
cells in DMEM plus 10% fetal bovine serum or NIH 3T3 cells in
DMEM plus 10% calf serum were seeded at 50% con£uency onto
glass cover slips in 35 mm tissue culture dishes. Plasmid (1 mg) and
Lipofectamine (6 ml) were mixed with serum free media (100 ml) and
incubated for 30 min at room temperature. The cells were rinsed once
with serum free media and then overlaid with the plasmid/lipofectam-
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 2 3 6 6 - 8
*Corresponding author. Fax: (1)-615-343 7347.
E-mail: david.e.ong@vanderbilt.edu
Abbreviations: CRABP, cellular retinoic acid binding protein; CRBP,
cellular retinol-binding protein; RA, retinoic acid
FEBS 24457 27-12-00 Cyaan Magenta Geel Zwart
FEBS 24457FEBS Letters 487 (2000) 282^286
ine mix plus additional serum free media (800 ml). The cells were
placed in an incubator at 37‡C for 2.5 h, rinsed once in serum free
media and ¢nally covered with serum containing media. 48 h follow-
ing the transfection, cells were rinsed once with PBS and then ¢xed as
described below.
2.5. Immuno£uorescence
The paraformaldehyde and all detergents were prepared in PBS.
Transfected cells were ¢xed and permeabilized with one of the follow-
ing methods as indicated in Section 3: (1) immersion in ice-cold meth-
anol:acetone (1:1) for 2 min at 320‡C, (2) immersion in 3.5% para-
formaldehyde for 20 min at room temperature followed by a PBS
rinse and a 5 min incubation in 0.1% Triton X-100, (3) immersion
in 3.5% paraformaldehyde for 20 min at room temperature followed
by a PBS rinse and a 5 min incubation in 0.15% SDS or (4) immersion
in 3.5% paraformaldehyde for 20 min at room temperature followed
by a PBS rinse and a 5 min incubation in 40 mg/ml digitonin. Follow-
ing permeabilization, the cells were rinsed with PBS, incubated for 30
min at room temperature in bu¡er A (3% BSA in PBS) and incubated
with primary antibody (diluted in bu¡er A) overnight at 4‡C in a
humidi¢ed chamber. The cells were washed with PBS and incubated
for 30 min at 37‡C with Alexa 488-labeled goat anti-rabbit IgG (1 mg/
ml) diluted in bu¡er A, washed with PBS, and mounted onto slides
with Aquamount. The cells were visualized with a Zeiss Axiophot
microscope (Vanderbilt University Imaging Center) equipped for £uo-
rescence microscopy or with a Zeiss LSM 410 microscope for laser
scanning confocal microscopy (Vanderbilt University Imaging Cen-
ter). For the MitoTracker Red studies, transfected cells were incu-
bated for 30 min at 37‡C with MitoTracker Red (CMXRos) (50
nM). The cells were rinsed with PBS and ¢xed as described above.
2.6. Mitochondrial isolation
Bovine adrenal gland was obtained from a local slaughterhouse and
transported to the laboratory in 0.25 M sucrose (solution B) on ice.
The medulla was removed and the cortex was scraped from the cap-
sule. Mitochondria were prepared from the cortex using previously
described procedures [15]. All procedures were performed at 4‡C. The
cortical tissue was weighed and homogenized with ¢ve complete
passes of a Te£on homogenizer in three volumes of solution B. The
homogenate was diluted to twice the original volume with solution B,
¢ltered through glass wool and centrifuged at 600Ug for 10 min. The
supernatant liquid was removed and centrifuged at 6000Ug for 15
min. The supernatant liquid was discarded and the pellet was resus-
pended ¢rst in 500 ml with a ‘cold ¢nger’ and ¢nally to the original
volume in solution B. This suspension was centrifuged at 9750Ug for
15 min. The resulting pellet was resuspended in solution B (500 ml/g
of wet weight tissue). It should be noted that the addition of a bu¡er
or salt to the 0.25 M sucrose did not permit the retention of either
cytochrome c or CRABP with the mitochondria. Nycodenz solutions
at 9 and 35% were prepared in solution B. The isolated mitochondria
were further puri¢ed by centrifugation through a Nycodenz gradient
as previously described [16]. Fractions (250 ml) were collected from
the gradient and aliquots (25 ml) were subjected to 15% SDS^PAGE,
transferred to Immobilon and analyzed by Western blotting with anti-
bodies speci¢c for either CRABP or cytochrome c.
3. Results and discussion
Previous immunohistochemical studies from this laboratory
revealed that CRABP is restricted to the cytoplasmic com-
partment of cells in tissues where it is expressed [8]. In con-
trast, CRBP, a related protein of the same family, was shown
to be present in both the cytoplasm and the nucleus, as ex-
pected for a protein of this size [17]. Bovine adrenal gland is
known to be a rich source of both CRABP and CRBP [18],
but the speci¢c cellular and subcellular localizations of these
proteins had not yet been examined in this organ. We, there-
fore, examined bovine adrenal by immunohistochemistry with
antibodies speci¢c for either CRABP or CRBP to determine
sites of expression and intracellular location. Both CRABP
and CRBP immunostaining localized to the parenchymal cells
of the adrenal cortex but no staining was observed in the
medulla (data not shown). In addition, the staining pattern
of CRABP, but not CRBP, was restricted to the cytoplasmic
compartment of the cortical parenchymal cells (Fig. 1A^D).
In all CRABP expressing tissues examined by immunohisto-
chemistry in this laboratory, CRABP staining has consistently
been observed as exclusively cytoplasmic (unpublished re-
sults). From this experiment we conclude that CRABP is nor-
mally restricted to the cytoplasmic compartment of cells in
which it is expressed.
To test if CRABP would be excluded from the nucleus of
cells in culture that do not normally express this protein, we
transiently transfected the Cos-1 cell line with a mammalian
expression vector containing cDNAs encoding either CRABP
or, as a control, CRBP. Following transfection, the cells were
¢xed with 3.5% paraformaldehyde and subsequently permea-
bilized with 0.1% Triton X-100. The expressed proteins were
detected by immuno£uorescence with speci¢c antibodies and
examined by £uorescence microscopy. CRABP immuno£uo-
rescence was observed only in the cytoplasmic compartment
and exhibited a punctate pattern, suggesting a possible organ-
elle association (Fig. 2A). CRBP immuno£uorescence was
observed as a di¡use staining pattern throughout the cell,
including the nucleus (Fig. 2B). Interestingly, a di¡erence in
the ability to detect the two proteins by immuno£uorescence
was observed. Approximately 35% of the transfected cells ex-
pressing CRBP were visible by £uorescence microscopy while
only 7% of the CRABP expressing cells were visible. These
results could not be explained by di¡erences in the level of
protein expression since both proteins were expressed at ap-
proximately equal levels as determined by Western blotting
(data not shown). In an attempt to increase the number of
CRABP expressing cells visible by immuno£uorescence we
tested a panel of seven di¡erent polyclonal antibodies to
Fig. 1. Nuclear exclusion of CRABP in bovine adrenal cortical cells.
Immunohistochemical localization of CRABP and CRBP was per-
formed using an alkaline phosphatase based staining system (brown)
and a hematoxylin counter-stain (blue). A: Positive staining for
CRABP in adrenal cortical cells not counter-stained (1000U) and
(B) same as in (A) but counter-stained with hematoxylin to reveal
the nuclei. The lack of staining in the nucleus is evident. C: Positive
staining for CRBP in adrenal cortical cells not counter-stained
(1000U) and (D) same as in (C) but counter-stained with hematoxy-
lin to reveal the nuclei.
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this protein. No di¡erence in the number of CRABP express-
ing cells was detected following immuno£uorescence with any
of these antibodies. The presence of RA (1 mM) in the me-
dium of the transfected cells had no e¡ect on the observed
£uorescence staining pattern or the inability to see the
CRABP-transfected cells by immuno£uorescence (data not
shown). Extension of this experiment to both the ST15A
and NIH 3T3 cell lines con¢rmed that these results were not
cell line-speci¢c (data not shown). The patterns observed for
the transfected cells recapitulated the previous observations
for in situ expression and indicated that the mechanism of
nuclear exclusion for CRABP may be available to all cells
and does not require a special cell-speci¢c component in order
to be accomplished.
The majority of the CRABP protein was undetectable by
immuno£uorescence microscopy following paraformaldehyde
¢xation and Triton X-100 permeabilization. In an attempt to
increase the number of CRABP expressing cells that could be
seen by immuno£uorescence, di¡erent ¢xation and permeabi-
lization methods were employed. Following transient trans-
fection of ST15A cells with cDNA encoding CRABP, cells
were ¢xed with either methanol:acetone or 3.5% paraformal-
dehyde. The paraformaldehyde-¢xed cells were subsequently
permeabilized with either 0.1% Triton X-100, 0.2% SDS or 40
mg/ml digitonin. The treated cells were then probed with
CRABP speci¢c antibodies and analyzed by immuno£uores-
cence. As described in Fig. 1, only 7% of the cells transfected
with CRABP cDNA ¢xed with 3.5% paraformaldehyde and
permeabilized with Triton X-100 were visible by immuno£uo-
rescence microscopy and these cells exhibit a characteristic
punctate staining pattern (Fig. 3A). Fixation with methano-
l :acetone did not signi¢cantly alter either the punctate stain-
ing pattern or the number of CRABP expressing cells that
were visible by immuno£uorescence (Fig. 3B). However, ¢x-
ation with paraformaldehyde followed by permeabilization
with SDS resulted in a three-fold increase in the number of
cells that could be seen by immuno£uorescence (Fig. 3C).
Additionally, approximately 50% of these cells had lost their
punctate staining pattern. Fixation with paraformaldehyde
followed by digitonin permeabilization also resulted in a
three-fold increase in the number of cells that were visible
by £uorescence microscopy and a loss of the typical punctate
staining pattern in all cells examined (Fig. 3D). Similar ¢xa-
tion and permeabilization experiments performed on cells
transfected with CRBP cDNA did not result in a di¡erence
in the number of cells seen by immuno£uorescence (data not
shown). From these experiments we conclude that the method
of ¢xation and permeabilization is critical for observing nu-
clear exclusion and punctate staining of CRABP in trans-
fected cells. Variation in ¢xation methods may well explain
the con£icting immunolocalization results obtained by other
laboratories [9,10]. Additionally, since both SDS and digito-
nin permeabilization led to an increase in the number of
CRABP expressing cells visible by immuno£uorescence, it is
possible that these detergents released the binding protein
from its native position in the cell and exposed epitopes that
were not previously available to our antibodies.
A punctate staining pattern can be indicative of organelle
association. To determine if this was the cause of the staining
pattern observed, overlay experiments with organelle-speci¢c
£uorochromes were performed. Cos-1 cells transfected with
Fig. 2. Nuclear exclusion of CRABP in transfected cells. ST15A
cells were transfected with the pCMX mammalian expression vector
containing cDNAs encoding either: (A) CRABP or (B) CRBP. Fol-
lowing transfection, the cells were ¢xed with 3.5% paraformalde-
hyde, permeabilized with 0.1% Triton X-100 and protein expression
was monitored by immuno£uorescence as described under Section 2.
Note the punctate, nuclear-excluded pattern for CRABP in contrast
to the relatively homogeneous pattern for CRBP throughout the
cell.
Fig. 3. Immuno£uorescence pattern of CRABP varied with di¡erent
¢xation procedures. ST15A cells were transfected with the pCMX
mammalian expression vector containing cDNA encoding CRABP.
Following transfection the cells were processed with either: (A) 3.5%
paraformaldehyde and 0.1% Triton X-100, (B) methanol:acetone,
(C) 3.5% paraformaldehyde and 0.2% SDS or (D) 3.5% paraformal-
dehyde and 40 mg/ml digitonin as described under Section 2. Sub-
sequently, protein expression was detected by immuno£uorescence.
Treatment with digitonin led to the loss of the punctate pattern in
all £uorescing cells (D).
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cDNA encoding CRABP were incubated with £uorescent dyes
speci¢c for the Golgi (BODIPY TR ceramide), endoplasmic
reticulum (DiOC5), lysosomes (neutral red), and mitochondria
(MitroTracker Red). The cells were ¢xed with methanol:ace-
tone and probed by immuno£uorescence with antibodies spe-
ci¢c for CRABP. The coincidence of binding protein immu-
no£uorescence to organelle dye £uorescence was then
compared by laser scanning confocal microscopy. Neither
the Golgi, endoplasmic reticulum nor lysosome-speci¢c £uo-
rochrome staining patterns matched the patterns of CRABP
immuno£uorescence (data not shown). Only the mitochon-
drial-speci¢c dye produced a staining pattern that was coinci-
dent, by confocal microscopy, with the immuno£uorescence
pattern of CRABP (Fig. 4A^C). From this experiment we
conclude that CRABP associated with the mitochondria in
these transfected cells. This is consistent with the increased
but now di¡use signal seen after digitonin treatment, a deter-
gent typically used for dissolution of the mitochondrial mem-
brane.
As noted, bovine adrenal is a rich source of both CRABP
and CRBP and demonstrated restriction of CRABP staining
to the cytoplasmic compartment of cortical cells. Immunohis-
tochemical analysis by dye deposition does not a¡ord the res-
olution necessary to see an organelle-speci¢c staining pattern.
Consequently, to ensure that our cell culture results were not
based on a transfection artifact, we examined the location of
CRABP by subcellular fractionation of the adrenal cortex. A
crude preparation of mitochondria was prepared and further
puri¢ed by sedimentation through a Nycodenz gradient. The
fractions from this gradient were analyzed by Western blot-
ting with antibodies speci¢c for either CRABP, cytochrome c
or CRBP. Both CRABP and cytochrome c co-sedimented in
fractions 5^8 (Fig. 5). There was no immunodetectable CRBP
observed in these fractions (data not shown). As described in
Section 2, it should be emphasized that any deviation from
this mitochondrial preparation protocol resulted in a loss of
both CRABP and cytochrome c from the puri¢ed mitochon-
drial gradient fractions. From this experiment we conclude
that CRABP is normally associated with mitochondria in situ.
The discovery of the association of CRABP with mitochon-
dria reported here was unexpected. CRABP has been studied
for 25 years and has always presented as a soluble, presum-
ably cytosolic, protein [2]. Clearly, then, the association is
easily reversed and has not survived the procedures used to
obtain soluble extracts for study or puri¢cation of this pro-
tein. Similarly, some other mitochondrial proteins, such as
cytochrome c, are also easily lost to the soluble fraction dur-
ing cell disruption. Mitochondria have not previously been
considered to have any role in RA function or metabolism,
a possibility that must now be considered.
The only demonstrated function for CRABP is to bind RA.
Since this protein is associated with mitochondria, this implies
that mitochondria participate in RA management. Cells ex-
pressing CRABP have an increased ability to degrade RA [6]
and RA bound to CRABP is accessible for oxidation by cy-
tochrome P450s [7]. While it has been demonstrated that a
microsomal cytochrome P450, CYP26, is inducible by RA and
recognizes it as a substrate [19,20], this enzyme is not present
in mouse testis, a CRABP-containing organ, but is present in
mouse liver, which is CRABP negative [21]. A second murine
microsomal cytochrome P450 that metabolizes RA has been
described but its expression is also restricted to liver in the
adult [22]. Consequently, it should now be considered that the
mitochondrion could also play a role in RA catabolism in
those cells expressing CRABP.
Fig. 4. MitoTracker Red-stained mitochondria are coincident with
CRABP immuno£uorescence. Cos-1 cells were transfected with the
pCMX mammalian expression vector containing the CRABP
cDNA. 48 h following transfection, the cells were incubated with
MitoTracker Red, ¢xed with methanol:acetone probed by immuno-
£uorescence and viewed by laser scanning confocal microscopy as
described in Section 2. A: CRABP immuno£uorescence. B: Mito-
Tracker Red staining pattern. C: Overlay of CRABP immuno£uo-
rescence and MitoTracker Red. Note the similar patterns in A and
B, as revealed by the overlay in C.
Fig. 5. CRABP co-sediments with bovine adrenal mitochondria. A
crude preparation of mitochondria was prepared and centrifuged
through a Nycodenz gradient as described in Section 2. Fractions
from this gradient were analyzed by Western blotting with antibod-
ies speci¢c for either (A) CRABP or (B) cytochrome c.
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In 1973 it was proposed that the action of RA would be
similar to that of steroid hormones [23]. This was con¢rmed
by the discovery of the RA nuclear receptor proteins. This
analogy may be extended further. Since the ¢rst step in the
inactivation of calcitriol (vitamin D3) is a mitochondrial hy-
droxylation, it is possible that the RA binding protein allows
the passage of RA or RA derived-compounds into the mito-
chondria for further processing.
Future studies will be necessary to determine the speci¢c
compartment of the mitochondria to which CRABP is tar-
geted. Because this protein is di⁄cult to retain within the
mitochondria during cell fractionation, it is likely that it is
present in the intermembrane space or attached to the outer
membrane. It will be of interest to determine which amino
acid residues are involved in: (1) the possible import of
CRABP into mitochondria and (2) the targeting of this bind-
ing protein to its proper organelle membrane or space. In
comparison with the nuclear e¡ects of RA, little is known
about the regulation of its synthesis and degradation. The
results presented here open many new areas of investigation.
Future studies will be aimed at identifying the role of CRABP
in the mitochondrion and in RA management.
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